{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:35:14Z","timestamp":1794072914605,"version":"4.8.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Inhibitors are the most severe complication of replacement therapy in patients with hemophilia. Previous studies, along with our clinical observations, have identified distinct incidence rates and clinical manifestations of factor VIII (FVIII) and FIX inhibitors in patients with severe hemophilia A (HA) and HB. To explore different immune responses to FVIII and FIX in patients with HA and HB and elucidate the mechanisms underlying the varying clinical manifestations of these patients, we performed single-cell sequencing on peripheral blood mononuclear cells (PBMCs) collected from 5 patients with HA and 5 with HB with inhibitors. After quality control, a total of 75\u2009051 cells were clustered into 19 subsets. Transcriptome analysis revealed differences in the composition of lymphocyte subsets and the functional status of immune cells between the HA and HB groups. Additionally, immune repertoire analysis indicated variations in the diversity of B- and T-cell clones between the 2 groups. HA group exhibited a relatively higher proportion of B cells and more active B cells, whereas HB group demonstrated a higher proportion of T cells, with more active CD4+ T helper cells. Our study provides insights into the distinct biological processes underlying the distinct immune responses to therapeutic FVIII and FIX in patients with HA and HB, as revealed through single-cell sequencing of PBMCs from patients with hemophilia with inhibitors. The data generated will serve as a valuable resource for future research on how the immune system recognizes and initiates responses to antigens with varying molecular characteristics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025015799","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:12:23Z","timestamp":1747908743000},"page":"3967-3978","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3033-7265","authenticated-orcid":false,"given":"Enhao","family":"Li","sequence":"first","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-4590","authenticated-orcid":false,"given":"Zekun","family":"Li","sequence":"additional","affiliation":[{"name":"3Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzeng","family":"Wang","sequence":"additional","affiliation":[{"name":"4Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Xue","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-8503","authenticated-orcid":false,"given":"Can","family":"Lou","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[{"name":"3Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China"},{"name":"5National Center for Children\u2019s Health, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[{"name":"4Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenman","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"6Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulan","family":"Ding","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"6Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[{"name":"3Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China"},{"name":"5National Center for Children\u2019s Health, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"6Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-5760","authenticated-orcid":false,"given":"Jing","family":"Dai","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"4Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"9371","key":"2025081209563603200_bib1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"2025081209563603200_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1134\/S1022795421080111","article-title":"Genetic risk factors for inhibitor development in hemophilia A","volume":"57","author":"Pshenichnikova","year":"2021","journal-title":"Russ J Genet"},{"issue":"2","key":"2025081209563603200_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/blood-2014-10-551952","article-title":"How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors","volume":"126","author":"Leissinger","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2025081209563603200_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"2025081209563603200_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1050-1738(00)00070-0","article-title":"Activation of factor IX by factor XIa","volume":"10","author":"Gailani","year":"2000","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2025081209563603200_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1612943","article-title":"The North American immune tolerance registry: practices, outcomes, outcome predictors","volume":"87","author":"DiMichele","year":"2002","journal-title":"Thromb Haemost"},{"issue":"1","key":"2025081209563603200_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"119","key":"2025081209563603200_bib8","first-page":"55091","article-title":"Generation of integration-free induced pluripotent stem cells from human peripheral blood mononuclear cells using episomal vectors","volume":"2017","author":"Wen","year":"2017","journal-title":"J Vis Exp"},{"issue":"6","key":"2025081209563603200_bib9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.cell.2016.05.057","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"issue":"1","key":"2025081209563603200_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2025081209563603200_bib11","doi-asserted-by":"crossref","first-page":"112487","DOI":"10.1016\/j.celrep.2023.112487","article-title":"A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"2025081209563603200_bib12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"issue":"9","key":"2025081209563603200_bib13","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.1502163","article-title":"CD83 modulates B cell activation and germinal center responses","volume":"196","author":"Krzyzak","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"2025081209563603200_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"2025081209563603200_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41590-025-02102-0","article-title":"B cell immunometabolism in health and disease","volume":"26","author":"Martinis","year":"2025","journal-title":"Nat Immunol"},{"issue":"6","key":"2025081209563603200_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10565-018-9426-0","article-title":"History, applications, and challenges of immune repertoire research","volume":"34","author":"Liu","year":"2018","journal-title":"Cell Biol Toxicol"},{"issue":"10","key":"2025081209563603200_bib17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1084\/jem.20040437","article-title":"Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense","volume":"200","author":"Messaoudi","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"2025081209563603200_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/341939","article-title":"Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children","volume":"186","author":"McFarland","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"2025081209563603200_bib19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4049\/jimmunol.179.2.1331","article-title":"Clonal expansion of CD8+ effector T cells in childhood tuberculosis","volume":"179","author":"Jacobsen","year":"2007","journal-title":"J Immunol"},{"key":"2025081209563603200_bib20","first-page":"221","article-title":"Recent advances in the treatment of hemophilia: a review","volume":"15","author":"Marchesini","year":"2021","journal-title":"Biologics"},{"issue":"13","key":"2025081209563603200_bib21","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood-2014-08-535328","article-title":"FVIII inhibitors: pathogenesis and avoidance","volume":"125","author":"Astermark","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2025081209563603200_bib22","doi-asserted-by":"crossref","first-page":"102248","DOI":"10.1016\/j.rpth.2023.102248","article-title":"Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration","volume":"7","author":"Sherman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"2025081209563603200_bib23","doi-asserted-by":"crossref","first-page":"101509","DOI":"10.1016\/j.isci.2020.101509","article-title":"The whole body as the system in systems immunology","volume":"23","author":"Poon","year":"2020","journal-title":"iScience"},{"issue":"6","key":"2025081209563603200_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/pch\/13.6.499","article-title":"Performing bone marrow aspiration and biopsy in children: Recommended guidelines","volume":"13","author":"Abla","year":"2008","journal-title":"Paediatr Child Health"},{"issue":"2","key":"2025081209563603200_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12016-009-8117-2","article-title":"A cellular viewpoint of anti-FVIII immune response in hemophilia A","volume":"37","author":"Andr\u00e9","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2025081209563603200_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.blre.2011.10.001","article-title":"Requirements for immune recognition and processing of factor VIII by antigen-presenting cells","volume":"26","author":"van Haren","year":"2012","journal-title":"Blood Rev"},{"issue":"3","key":"2025081209563603200_bib27","first-page":"290","article-title":"Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells","volume":"142","author":"Kaczmarek","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2025081209563603200_bib28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/hae.12158","article-title":"Inhibitors in haemophilia B: the Italian experience","volume":"19","author":"Castaman","year":"2013","journal-title":"Haemophilia"},{"issue":"6","key":"2025081209563603200_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0038-1660817","article-title":"Inhibitors in Hemophilia B","volume":"44","author":"Santoro","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"2025081209563603200_bib30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fimmu.2020.01219","article-title":"Hemophilia A inhibitor subjects show unique PBMC gene expression profiles that include up-regulated innate immune modulators","volume":"11","author":"Karim","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"2025081209563603200_bib31","doi-asserted-by":"crossref","first-page":"e12794","DOI":"10.1002\/rth2.12794","article-title":"Risk factors for inhibitors in hemophilia A based on RNA-seq and DNA methylation","volume":"6","author":"Liu","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2025081209563603200_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2025081209563603200_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1160\/TH05-11-0729","article-title":"Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells","volume":"96","author":"Pfistershammer","year":"2006","journal-title":"Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3967\/2404906\/blooda_adv-2025-015799-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3967\/2404906\/blooda_adv-2025-015799-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:56:45Z","timestamp":1755007005000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/15\/3967\/537383\/Single-cell-sequencing-on-PBMCs-from-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025015799","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,12]]},"published":{"date-parts":[[2025,7,31]]}}}